Please login to the form below

Not currently logged in
Email:
Password:

Turnstone Biologics

This page shows the latest Turnstone Biologics news and features for those working in and with pharma, biotech and healthcare.

Transgene slumps as viral cancer therapy fails phase 3 trial

Transgene slumps as viral cancer therapy fails phase 3 trial

have tied up with Turnstone Biologics and BeneVir Biopharm, respectively.

Latest news

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    targeting drugs from the likes of Crescendo Biologics and Pfizer, and Celldex’ CD27-targeting antibody varlilumab which is in phase II testing for various solid tumour types. ... Meanwhile, AbbVie and Johnson &Johnson have both struck deals this year

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • BMS’ Dr Mike Burgees joins Turnstone Biologics BMS’ Dr Mike Burgees joins Turnstone Biologics

    He joins the immuno-oncology group as its president of R&D. Turnstone Biologics, a North American clinical-stage immuno-oncology company, has appointed Dr Mike Burgees as its president of ... He said: “ Turnstone Biologics is uniquely positioned to

  • Turnstone Biologics bolsters leadership team Turnstone Biologics bolsters leadership team

    Kris Elverum and José Otero join the group. Canadian immuno-oncology company Turnstone Biologics has strengthened its leadership team with the addition of two new hires. ... Sammy Farah, chief executive officer, Turnstone Biologics, said: “The

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...
What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...

Infographics